These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2228821)
1. Epidemiology of antibiotic-inactivating enzymes and DNA probes: the problem of quantity. Martinez JL; Baquero F J Antimicrob Chemother; 1990 Sep; 26(3):301-3. PubMed ID: 2228821 [No Abstract] [Full Text] [Related]
2. In-vitro sensitivity of amoxicillin/clavulanic acid (Augmentin) to isolated beta-lactamases and in-vitro antibacterial activity. Esposito S; Noviello S J Chemother; 1990 Jun; 2(3):167-70. PubMed ID: 2380766 [TBL] [Abstract][Full Text] [Related]
3. Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group. Chardon H; Farzaneh S; Labia R; Jarlier V; Nicolas MH; Paul G; Poyart C; Sirot D; Sirot J J Antimicrob Chemother; 1995 Jul; 36(1):267-9. PubMed ID: 8537279 [No Abstract] [Full Text] [Related]
4. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989. Seetulsingh PS; Hall LM; Livermore DM J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685 [TBL] [Abstract][Full Text] [Related]
5. Beta-lactamase evaluation of the amoxycillin-clavulanate association. Novelli A; Reali EF; Fallani S; Periti P Drugs Exp Clin Res; 1989; 15(4):151-4. PubMed ID: 2505995 [TBL] [Abstract][Full Text] [Related]
9. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid. Thomson CJ; Amyes SG J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208 [TBL] [Abstract][Full Text] [Related]
11. Amoxycillin/clavulanate resistant Escherichia coli. Williams H; King A; Shannon K; Phillips I Lancet; 1988 Feb; 1(8580):304-5. PubMed ID: 2893121 [No Abstract] [Full Text] [Related]
12. Inactivation of amoxycillin, clavulanate and the combination by faecal preparations from volunteers. Welling GW; Groen G J Antimicrob Chemother; 1990 Feb; 25(2):301-2. PubMed ID: 2329109 [No Abstract] [Full Text] [Related]
13. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases. Marre R; Schulz E Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383 [TBL] [Abstract][Full Text] [Related]
14. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments. Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958 [TBL] [Abstract][Full Text] [Related]
15. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene. Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130 [TBL] [Abstract][Full Text] [Related]